Inflammation in COPD: pathogenesis, local and systemic effects

被引:18
作者
Barbu, Cornelia [1 ]
Iordache, Mihaela [1 ]
Man, M. G. [1 ]
机构
[1] Univ Pitesti, Arges Cty Hosp, Dept Internal Med, Pitesti 110084, Romania
关键词
COPD; local inflammation; systemic inflammation; systemic manifestations; OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; AIRWAY INFLAMMATION; ASYMPTOMATIC SMOKERS; EXACERBATIONS; SMOKING; ASSOCIATION; INFECTIONS; CYTOKINES; RECOVERY;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
COPD is a disease characterized by inflammation both in its stable phase and during exacerbations. Inflammation is present in the respiratory compartment, the inflammatory cells and different mediators of inflammation being present. Studies have shown that some mediators of inflammation have a high level at systemic level also, inducing a certain grade of systemic inflammation, mainly responsible for the systemic manifestation of the disease. It seems that the both local and the systemic inflammation are amplified during exacerbations. The purpose of this paper is to review the respiratory inflammatory reaction, to identify the main actors involved in the stable phase of the disease and during exacerbations, the systemic inflammation accompanying the local inflammation, and to find the possible interrelations between the systemic and local inflammation, on one hand, and the respiratory and extra-respiratory manifestations of COPD on the other hand. The understanding of the pathogenic mechanisms, which stay at the base of inflammation and of the possible interrelations shown, represents a theoretical interest and also a practical one, concerning the targets of different therapeutic agents which could be used in the management and in the control of the disease.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 43 条
[1]
Hypothesis: Does COPD have an autoimmune component? [J].
Agusti, A ;
MacNee, W ;
Donaldson, M ;
Cosio, M .
THORAX, 2003, 58 (10) :832-834
[2]
Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM
[4]
Chronic obstructive pulmonary disease: molecular and cellular mechanisms [J].
Barnes, PJ ;
Shapiro, SD ;
Pauwels, RA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :672-688
[5]
Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217
[6]
Leptin and atherosclerosis [J].
Beltowski, Jerzy .
ATHEROSCLEROSIS, 2006, 189 (01) :47-60
[7]
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial [J].
Brightling, CE ;
Monteiro, W ;
Ward, R ;
Parker, D ;
Morgan, MDL ;
Wardlaw, AJ ;
Pavord, ID .
LANCET, 2000, 356 (9240) :1480-1485
[8]
Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease [J].
Creutzberg, EC ;
Wouters, EFM ;
Vanderhoven-Augustin, IML ;
Dentener, MA ;
Schols, AMWJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1239-1245
[9]
The interactions between inflammation and coagulation [J].
Esmon, CT .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (04) :417-430
[10]
Ferroni P, 2000, J INVEST MED, V48, P21